Embolic Stroke
8
1
1
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
25%
2 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (8)
Left Atrial Appendage Closure as Secondary Prevention of Atrial Fibrillation-related Embolic Events
Long-term Outcomes After Percutaneous Closure of PFO
Norwegian Carotid Plaque Study
Shuxuetong for Prevention of Recurrence in Acute Cerebrovascular Events With Embolism
Norwegian Microemboli in Acute Stroke Study
Perfusion Pressure Cerebral Infarction Trial (PPCI)
Study of Antiplatelet Therapy for Intracranial Aneurysm Stent-assisted Coiling
Study of the Efficacy, Safety and Tolerability of Low Molecular Weight Heparin vs. Unfractionated Heparin in Stroke